GLP-1 therapy, often used to aid in weight loss and blood sugar management, works by mimicking the effects of glucagon-like peptide-1 (GLP-1)
Most common side effects were gastrointestinal, with 24.5% of participants in the phase 2 obesity trial discontinuing efinopegdutide 10 mg due to AE however when the same dose was used with gradual escalation at the MASLD trial (starting dose 2.4 mg for 4 weeks, then 5 mg for 4 weeks and then 10 mg), only 5.6% of participants discontinued the medication due to AE
Rated 4.7/5 by 29 verified customers 10mg Ships Tomorrow morning if ordered within 19 hrs 32 min
This is the most common source of dosing error in the research setting: reading 10 units as a fixed truth when it is really a property of the 3 mL preparation
Using BPC-157 continuously without breaks may reduce responsiveness over time
Stores of vitamin B12 in the body can last around 2 to 5 years without being replenished, so it can take a long time for any problems to develop after a dietary change